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Introduction
Background: Little is known about the vaso-
motor function of human coronary collateral
vessels. The purpose of this study was to examine
collateral flow under a strong sympathetic stimu-
lus (cold pressor test, CPT).
Methods: In 30 patients (62 ± 12 years) with
coronary artery disease, two subsequent coronary
artery occlusions were performed with random
CPT during one of them. Two minutes before and
during the 1 minute-occlusion, the patient’s hand
was immerged in ice water. For the calculation of
a perfusion pressure-independent collateral flow
index (CFI), the aortic (Pao), the central venous
(CVP) and the coronary wedge pressure (Poccl)
were measured: CFI = (Poccl – CVP) / (Pao – CVP).
Results: CPT lead to an increase in Pao from
98 ± 14 to 105 ± 15 mm Hg (p = 0.002). Without
and with CPT, CFI increased during occlusion
from 14% ± 10% to 16% ± 10% (p = 0.03) and
from 17% ± 9% to 19% ± 9% (p = 0.006), respec-
tively, relative to normal flow. During CPT, CFI
was significantly higher at the beginning as well as
at the end of the occlusion compared to identical
instants without CPT. CFI at the end of the con-
trol occlusion did not differ significantly from the
CFI at the beginning of occlusion with CPT.
Conclusions: During balloon occlusion, collat-
eral flow increased due to collateral recruitment
independent of external sympathetic stimulation.
Sympathetic stimulation using CPT additionally
augmented collateral flow. The collateral-flow-
increasing effect of CPT is comparable to the
recruitment effect of the occlusion itself. This may
reflect a coronary collateral vasodilation mediated
by the sympathetic nervous system.
Keywords: coronary collateral circulation; ischaemic
preconditioning; walking through angina; sympathetic
nervous system; cold pressor test
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Summary
The “walking through phenomenon” in an-
gina pectoris describes a condition of chest pain
after the beginning of physical activity and sub-
sequent relief during persistent physical exercise
[1, 2]. Similar symptoms can be found in patients
with intermittent claudication. Thulesius showed
in patients with “walking through phenomenon”
in intermittent claudication, that during exercise
of the affected musculature a vasodilation of col-
lateral vessels occurs [3]. Traditionally, “walking
through” angina has been interpreted as coronary
collateral channel opening during exercise-
induced myocardial ischaemia [4–6]. However,
this could not be demonstrated by coronary an-
giography [7]. Recently, it has been demonstrated
that repeated episodes of ischaemia during percu-
taneous transluminal coronary angioplasty (PTCA)
result in an increase in collateral flow as assessed
by coronary wedge-pressure measurements [8],
either caused by opening of preexisting underper-
fused or by dilation of already perfused collateral
vessels. Although coronary collateral recruitment
could never be demonstrated using coronary
angiography, the positive results of this study [8]
can largely be attributed to the high sensitivity 
of the method for the assessment of collateral flow
[9, 10].
Little is known about vasomotor properties of
human coronary collateral vessels, in particular 
the role of sympathetic nervous activation, such as
during exercise or during myocardial ischaemia.
Experimental studies have indicated that increased
sympathetic tone results in augmented collateral
flow [11–13]. The purpose of this study was to 
test clinically the hypothesis that activation of the
sympathetic nervous system using the cold pressor
test (CPT) causes an increase in coronary collat-
eral flow. 
Abbreviation list
CAD coronary artery disease
CFI collateral flow index
CPT cold pressor test
CVP (mm Hg) central venous pressure
Pao (mm Hg) mean aortic pressure
Poccl (mm Hg) mean coronary wedge-pressure
PTCA percutaneous transluminal coronary 
angioplasty
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Patients
Thirty patients (age 62 ± 12 years, 24 men, 6 women)
with one or two vessel coronary artery disease (CAD) were
included in the study. All patients underwent routine per-
cutaneous transluminal coronary angioplasty (PTCA) of 
a single lesion. Patients were included if the following in-
clusion criteria were fulfilled: absence of unstable angina
pectoris, absence of acute or previous myocardial Q-wave
infarction, absence of total coronary occlusion. The mag-
nitude of collateral vessels visualized during coronary an-
giography was not a criterion for inclusion or exclusion. 
The patients gave informed consent to participate in
the study. 
Coronary angioplasty, assessment of haemodynamic
parameters, and ischaemia
Diagnostic coronary angiography was performed
from the right femoral approach using 5F Judkins
catheters for both, left and right coronary arteries. For
PTCA 6F guiding catheters were used. Mean coronary
wedge pressure measurements (Poccl) were performed
using PTCA guide wires equipped with pressure sensors
at the tip of the wire (WaveWire®, Endosonics, Rancho
Cordova, California USA) (figure 1). Mean aortic pres-
sure (Pao) was measured via the guiding catheter. Central
venous pressure was measured from a second catheter in
the right atrium. An intracoronary ECG obtained from
the guide wire was recorded in 26 patients in addition to
three standard limb leads (figure 1). The ST-segment
changes were normalized for the respective R-wave am-
plitude. Heart rate was assessed from the ECG and the
pressure-rate product (Pao  heart rate) was calculated. 
All parameters were recorded continuously. Measure-
ments were performed at the beginning and at the end of
each 1-minute coronary balloon occlusion.
Coronary collateral assessment
Collateral flow index (CFI) was calculated as the dis-
tal perfusion pressure during vessel occlusion, normalized
to the perfusion pressure during vessel patency, according
to the following formula: 
CFI = (Poccl –CVP) / (Pao –CVP).
This method has recently been validated against in-
tracoronary Doppler flow velocity measurements for the
assessment of collateral flow [10].
Study protocol
Coronary angiography and biplane ventricular an-
giography were performed before inclusion into the study.
In order to avoid overlapping effects, no nitroglycerin was
given until completion of the study protocol. All patients
underwent two balloon occlusions of 1 minute duration,
during which simultaneous aortic and coronary pressure
measurements were performed to assess the CFI (figure
1). CPT, consisting of immerging the patient’s hand in ice
water, has frequently been validated for activation of the
sympathetic nervous system [14, 15]. The sympathetic
activation increases immediately after beginning of the
CPT. After two minutes, a very consistent elevation is
achieved [14, 15]. In our study, the test was started 2 min-
utes before and continued during the 1-minute coronary
occlusion. Since collateral recruitment occurs with each
occlusion [8], the CPT was randomly assigned to one 
of the two occlusions. 
Statistical analysis
For comparisons of continuous variables between
groups, unpaired Student’s t-tests were performed. For
intraindividual comparisons of hemodynamic data with
and without CPT, paired Student’s t-tests were used.
Mean values ± standard deviations are given. To assess the
correlation between continuous variables, linear regres-
sion analyses were performed. Statistical significance was
defined at a p value <0.05. 
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Methods
Figure 1
Figure 1a shows the inflated balloon across
a stenosis in the LAD in a patient with coronary
collaterals insufficient to prevent myocardial
ischemia. Coronary perfusion pressure deter-
mined by the blood flow distal to the 
occluded stenosis (i.e. collateral flow) is mea-
sured (Poccl) via the pressure wire located distal
to the stenosis. Collateral flow index (CFI) 
is calculated as indicated in figure 1b. 
ST-segment elevations are observed in the 
intracoronary ECG during balloon occlusion
(asterixes).
Abbreviations: CFI = collateral flow index, CVP
= central venous pressure, LAD = left anterior
descending coronary artery, RCA = right 
coronary artery, Pao = mean aortic pressure,
Poccl = coronary wedge pressure.
1a 1b
Patient characteristics 
Patient characteristics are summarized in table
1. Seventeen patients were on beta-blocking
agents, 4 patients on ACE-inhibitors or an-
giotensin-antagonists and 8 patients on calcium
antagonists at the time of the study. In twelve
patients, CPT was performed during the first of
the two occlusions.
Effects of cold pressor test (CPT)
Average data of CFI, coronary wedge pressure
(Poccl), mean aortic pressure (Pao), heart rate, pres-
sure-rate product, central venous pressure, and
ST-segment changes (normalized to the respective
R-wave amplitude) on intracoronary ECG are
given in table 2. There was a significant increase
of CFI during each occlusion, reflecting collateral
recruitment during ischaemia (figure 2). In addi-
tion, when comparing CFI without and with CPT
at the beginning as well as at the end of occlusion,
a significant increase in CFI could be observed
(figure 2). No differences in CFI were found be-
tween the end of occlusion without CPT and the
beginning of occlusion with CPT. Differences in
heart rate between the beginning and the end of
occlusion without and with CTP differed signifi-
cantly except for the change during the occlusion
with CPT (table 2). Mean aortic pressure showed
a pattern similar to the heart rate regarding CPT-
induced changes. Again, the changes during the
occlusion with CPT were not significant (table 2).
Consequently, the pressure-rate product also in-
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Results
Age (years) 62 ± 12
Gender (male / female) 24 / 6
Systolic aortic pressure (mm Hg) 128 ± 10
Diastolic aortic pressure (mm Hg) 70 ± 10
Mean aortic pressure (mm Hg) 91 ± 12
Central venous pressure (mmHg) 6 ± 3
Heart rate (beats per minute) 70 ± 13
Left ventricular ejection fraction (%) 64 ± 8
1-/2-vessel disease 22 / 8
Target lesion for PTCA (LAD / LCX / RCA) 15 / 5 / 10
Resting transstenotic gradient (mm Hg) 17 ± 22
Collateral flow index (%) 14 ± 10
No intracoronary ECG changes during PTCA 24 / 26
Continuous variables are given in mean ± standard deviation. 
Abbreviations: LAD = left anterior descending coronary
artery, LCX = left circumflex coronary artery, 
PTCA = percutanous transluminal coronary angioplasty,
RCA = right coronary artery.
Table 1
Patient characteris-
tics.
Figure 2
Collateral flow index (CFI, vertical axis) at the
beginning and at the end of 1 minute balloon
occlusions without and with cold pressor test
(CPT), respectively. The CFI changes are addi-
tionally given for each individual (solid lines).
A significant overall increase in CFI due to the
CPT can be observed, although the CFI did not
change or even decrease after CPT in a num-
ber of patients. Furthermore, collateral recruit-
ment during each occlusion could be de-
monstrated, independent of the presence 
or absence of sympathetic stimulation. 
Abbreviations: CFI = collateral flow index, 
CPT = cold pressor test
Occlusion without CPT Occlusion with CPT
beginning end beginning end
CFI (%) 14.0 ± 10.3 15.9 ± 9.8a 17.3 ± 9.1 18.7 ± 8.9
Poccl (mm Hg) 18.5 ± 9.0 21.0 ± 8.8a 22.4 ± 10.2 24.7 ± 9.9
Pao (mm Hg) 99 ± 14b 100 ± 13 105 ± 15c 105 ± 15
HR (bpm) 65.2 ± 13.9 67.3 ± 14.2 71.3 ± 16.2c 70.8 ± 16.8
PRP (mm Hg  bpm) 6461 ± 1825 6800 ± 1901 7583 ± 2444c 7483 ± 2425
CVP (mm Hg) 6.5 ± 2.6d 7.6 ± 2.8 6.8 ± 2.6d 8.0 ± 2.4
ST 0.31 ± 0.24c 0.30 ± 0.21
Abbreviations: CFI = collateral flow index, CVP = central venous pressure, HR = heart rate, 
Pao = mean aortic pressure, Poccl = coronary wedge pressure, PRP = pressure-rate product, 
ST = ST-segment changes in intracoronary ECG (normalized for respective R-wave amplitude). 
All changes in hemodynamic data are significant, if not indicated otherwise (a p>0.05 vs. beginning
of occlusion with CPT; b p>0.05 vs. end of occlusion without CPT; c p>0.05 vs. end of occlusion with
CPT; d p>0.05 vs. end of occlusion).
Table 2
Parameters at the
beginning and at the
end of occlusion
without and with
CPT.
creased during the occlusion without CPT and as
a result of the CPT, but not during the occlusion
with CPT (table 2). The central venous pressure
significantly increased during both occlusions, sig-
nificantly diminished between the end of occlusion
without and with CPT, but remained unchanged
when the effect of the CPT was analysed (table 2).
Poccl behaved similarly regarding CFI changes and
statistical significance levels (table 2). 
No intracoronary ECG ST-segment changes
were observed at the beginning of any occlusion.
Overall, ST-segment changes did not differ statis-
tically between the two occlusions at their end
point (table 2).
Determinants of ischaemia
The CFI was inversely and linearly related to
ST-segment changes at the end of both occlusions
as well as in an overall analysis of occlusions with-
out and with CPT (r = –0.31, p = 0.02, figure 3). 
No associations were found between CPT-in-
duced changes in intracoronary ECG ST-segment
and pressure-rate product, drug intake, heart rate,
target lesion, number of contralateral stenotic le-
sions and initial transstenotic pressure gradient
using univariate analysis.
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Figure 3
Correlation between ST-segment changes 
(vertical axis) and collateral flow index 
(horizontal axis) at the end of occlusion. There
is a significant inverse linear relationship be-
tween signs of ischaemia and collateral supply
during vessel occlusion with and without cold
pressor test. 
Abbreviations: CFI = collateral flow index, 
ST = ST-segment changes in intracoronary ECG
(changes normalized for respective R-wave
amplitude)
Discussion
This study demonstrated in a model using the
CPT in humans that sympathetic activation pro-
duces an increase in coronary collateral flow inde-
pendently of collateral recruitment and ischaemic
preconditioning caused by repeated episodes of
ischaemia. 
Stimulation of peripheral cold receptors have
been shown to strongly activate the sympathetic
nervous system [11]. In particular, the activation 
of the muscle sympathetic nerve activity, i.e. the
system regulating the systemic blood pressure,
could be demonstrated directly using microneu-
rography within the peroneal nerve in humans
[11–16]. In cardiac sympathetic fibers, there is
indirect evidence that the CPT increases their
activity [11]. In humans, only indirect evidence of
sympathetic effects on coronary vessels can be
assessed, such as vasomotion in angiography or
changes of coronary pressure or flow velocity. The
coronary vasomotor response to sympathetic stim-
ulation is a result of a complex interaction between
adrenergic receptor activation and local metabolic
changes. The functional integrity of the endothe-
lium plays an important role for the reaction of the
coronary vessels to sympathetic stimuli [17–20].
Few experimental investigations on vasomotor
properties of coronary collateral vessels have been
published [21, 22]. These studies suggest that the
sympathetic nervous system might predominantly
(or exclusively) exert beta-receptor-mediated (i.e.
vasodilative) effects on coronary collaterals. Other
mediators for vasodilatation, like adenosine
triphosphate release by sympathetic nerve endings
or local metabolites, cannot be excluded [23]. 
Active collateral vasodilation vs. passive 
collateral flow increase
An increase in collateral flow can either be ini-
tiated by collateral vasodilation with subsequent
reduction of the collateral vascular resistance, or
by collateral channel opening (i.e. collateral re-
cruitment) and passive reduction of the overall
collateral vascular resistance. If the latter mecha-
nism was operative in our study, the sympathetic
nervous system-induced vasoconstriction in the
collateral-supplying microvascular bed (contralat-
eral area) must have been more pronounced than
in the collateral-receiving vascular bed (ipsilateral
area), causing a more pronounced intracoronary
pressure drop ipsi- than contralateral. Since vaso-
constrictor response is largely dependent on en-
dothelial function [17], the degree of endothelial
dysfunction must have been systematically more
severe in the contralateral coronary artery than in
the artery referred for PTCA. Our study patients,
however, had more severe ipsilateral coronary ar-
tery disease: only 8 patients had concomitant
contralateral stenoses. Thus, it seems unlikely that
unequal microvascular vasoconstriction between
ipsi- and contralateral vascular beds may have led
to an increase in collateral flow during the cold
pressor test, but rather a sympathetic-mediated
collateral vasodilation.
Myocardial ischaemia during sympathetic
stimulation
The inverse relation between CFI and ST-
segment changes reflects the potentially protective
role of collaterals during vessel occlusion (figure
3); a well known phenomenon [8, 9, 24, 25]. Sym-
pathetic stimulation using the CPT was associated
with a significant increase of the pressure-rate
product, thus indirectly demonstrating that myo-
cardial oxygen demand was increased. Since myo-
cardial ischaemia results from an imbalance be-
tween oxygen supply and myocardial oxygen de-
mand, our results suggest that the overall effect of
CPT-induced increase of the pressure-rate prod-
uct on myocardial ischaemia is counterbalanced
but not overcompensated by the concomitant
increase in collateral flow (table 2). Myocardial
protection by collateral flow stimulation may thus
be an adaptive mechanism when the cardiovascu-
lar system is aroused by the sympathetic nervous
system. 
Study limitations
No test was performed to assess coronary
endothelial function, such as analysis of the ability
of the vasculature to dilate in response to intra-
coronary acetylcholine, an endothelium-depend-
ent vasodilator [19]. Impaired vasodilation or even
vasoconstriction would have given the possibility
to estimate the regional endothelial dysfunction,
hence the regional vasoconstrictor sensitivity to
sympathetic stimulation. As mentioned above,
however, our results suggest that vasomotion of
the ipsi- and contralateral coronary vascular bed 
in response to the sympathetic activation may have
counterbalanced rather than supported the ob-
served increase in collateral flow. 
There is a considerable proportion of patients
in whom CFI did not change or even decreased
during CPT. This decrease in CFI in response to
a sympathetic stimulus was also observed in a study
using positron emission tomography for calcula-
tion of regional myocardial blood flow in collateral
dependent and remote myocardium [26]. In that
study, only three out of nine patients had a collat-
eral flow increase during the CPT. The small num-
ber of patients studied, considering the high vari-
ability of collateral vessel response, might explain
the contradictory results when compared with our
study.
Since myocardial ischaemia itself can produce
either reflex-sympathetic excitation or depression
and vagal activation, mostly depending on the
affected myocardial region, the total sympathetic
drive to the coronary vessels cannot be considered
a result of the effect of the CPT alone. In our 
study, however, the CPT-induced increase in heart
rate indicates that the cardiac sympathetic nervous
system was activated.
The majority of patients (17/30) were under
beta-blocking agents at the time of cardiac cathe-
terization. Considering this subgroup separately,
CFI was not statistically different at the end of a
strong 3-minute sympathetic stimulus (i.e. CPT).
This observation is consistent with the concept of
beta-receptor mediated collateral vasodilatation
through sympathetic stimulation as the cause of
increased CFI. However, because of the small
study group, no further statistically relevant sub-
group analysis was possible.
Conclusions
Cardiac sympathetic stimulation induces an
increase in collateral flow. This effect is most 
likely attributable to collateral vasodilation, strong
enough to counterbalance possible vascular re-
distribution effects of unevenly constricting resist-
ance vessels in collateral receiving and supplying
myocardial areas. Despite increased myocardial
oxygen demand during sympathetic stimulation,
no increase in myocardial ischaemia was observed.
The development of myocardial tolerance to
ischaemia during persistent physical exercise may
thus be supported by a sympathetic-induced
dilatation of collateral vessels with subsequent
increase in collateral flow.
Correspondence: 
Prof. Christian Seiler MD
Swiss Cardiovascular Center Bern
University Hospital
Freiburgstrasse
CH-3010 Bern
E-mail: christian.seiler.cardio@insel.ch
S W I S S  M E D  W K LY 2 0 0 1 ; 1 3 1 : 3 5 1 – 3 5 6 ·  w w w. s m w. c h 355
References
1 Wenckebach K. Angina pectoris. München: 1926.
2 Osler W. Lectures on angina pectoris and allied states. New
York: D. Appelton and Co.; 1897. p. 52.
3 Thulesius O. Requirements for development of collateral cir-
culation. Vasa 1972;1:4–11.
4 Pentecost BL. Walking through angina [editorial]. Br Med J
1985;291:1069–70.
5 Gavazzi A, De Servi S, Cornalba C, Falcone C, Scuri PM, Spec-
chia G. Significance of the walk-through angina phenomenon
during exercise testing. Cardiology 1986;73:47–53.
6 Ohno A, Fujita M, Yamanishi K, Hirai T, Kameyama T, Araie
E, et al. Walk-through phenomenon by gradual recruitment of
collateral circulation. J Cardiol 1990;20:49–53.
7 MacAlpin RN, Kattus AA. Adaptation to exercise in angina
pectoris. Circulation 1966;33:183–201.
8 Billinger M, Fleisch M, Eberli FR, Garachemani A, Meier B,
Seiler C. Is the development of myocardial tolerance to repeated
ischaemia in humans due to preconditioning or to collateral re-
cruitment? J Am Coll Cardiol 1999;33:1027–35.
9 Meier B, Luethy P, Finci L, Steffenino GD, Rutishauser W.
Coronary wedge pressure in relation to spontaneously visible
and recruitable collaterals. Circulation 1987;75:906–13.
10 Seiler C, Fleisch M, Garachemani A, Meier B. Coronary col-
lateral quantitation in patients with coronary artery disease
using intravascular flow velocity or pressure measurements. J
Am Coll Cardiol 1998;32:1272–9.
11 Victor RG, Leimbach WN Jr., Seals DR, Wallin BG, Mark AL.
Effects of the cold pressor test on muscle sympathetic nerve
activity in humans. Hypertension 1987;9:429–36.
12 Noll G, Wenzel RR, de Marchi S, Shaw S, Luscher TF. Differ-
ential effects of captopril and nitrates on muscle sympathetic
nerve activity in volunteers. Circulation 1997;95:2286–92.
13 Hagbarth KE, Vallbo AB. Single unit recordings from muscle
nerves in human subjects. Acta Physiol Scand 1969;76:321–34.
14 Hagbarth KE, Hallin RG, Hongell A, Torebjork HE, Wallin
BG. General characteristics of sympathetic activity in human
skin nerves. Acta Physiol Scand 1972;84:164–76.
15 Delius W, Hagbarth KE, Hongell A, Wallin BG. General char-
acteristics of sympathetic activity in human muscle nerves. Acta
Physiol Scand 1972;84:65–81.
16 Delius W, Hagbarth KE, Hongell A, Wallin BG. Manoeuvres
affecting sympathetic outflow in human muscle nerves. Acta
Physiol Scand 1972;84:82–94.
17 Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H.
Coronary vasomotion in response to sympathetic stimulation 
in humans: importance of the functional integrity of the en-
dothelium. J Am Coll Cardiol 1989;14:1181–90.
18 Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of
coronary vasomotor tone in humans. Progressive endothelial
dysfunction with different early stages of coronary atheroscle-
rosis. Circulation 1991;83:391–401.
19 Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM,
Fish RD, et al. Patients with evidence of coronary endothelial
dysfunction as assessed by acetylcholine infusion demonstrate
marked increase in sensitivity to constrictor effects of cate-
cholamines. Circulation 1992;85:1390–7.
20 Billinger M, Fleisch M, Eberli FR, Meier B, Seiler C. Collat-
eral and collateral-adjacent hyperemic vascular resistance
changes and the ipsilateral coronary flow reserve. Documenta-
tion of a mechanism causing coronary steal in patients with
coronary artery disease. Cardiovasc Res 2001;49:600–8.
21 Maruoka Y, McKirnan MD, Engler RL, Longhurst JC. Func-
tional significance of alpha-adrenergic receptors in mature
coronary collateral circulation of dogs. Am J Physiol 1987;
253:H582–90.
22 Harrison DG, Chilian WM, Marcus ML. Absence of function-
ing alpha-adrenergic receptors in mature canine coronary
collaterals. Circ Res 1986;59:133–42.
23 Harrsion DG. Neurohumoral and pharmacologic regulation 
of collateral perfusion. In: Scharper W, Scharper J, eds. Collat-
eral circulation. Boston: Kluwer Academic Publishers; 1993. p.
329–36.
24 Gottwik MG, Puschmann S, Wusten B, Nienaber C, Muller
KD, Hofmann M, Schaper W.. Myocardial protection by col-
lateral vessels during experimental coronary ligation: a prospec-
tive study in a canine two-infarction model. Basic Res Cardiol
1984;79:337–43.
25 Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz
P. Value of the intracoronary electrocardiogram to monitor
myocardial ischaemia during percutaneous transluminal coro-
nary angioplasty. Circulation 1986;74:330–9.
26 Uren NG, Crake T, Tousoulis D, Seydoux C, Davies GJ, Maseri
A. Impairment of myocardial vasomotor response to cold
pressor test stress in collateral dependent myocardium. Heart
1997;78:61–7.
Cardiac sympathetic stimulation and collateral flow 356
What Swiss Medical Weekly has to offer:
• SMW’s impact factor has been steadily 
rising, to the current 1.537
• Open access to the publication via
the Internet, therefore wide audience 
and impact
• Rapid listing in Medline
• LinkOut-button from PubMed 
with link to the full text 
website http://www.smw.ch (direct link
from each SMW record in PubMed)
• No-nonsense submission – you submit 
a single copy of your manuscript by 
e-mail attachment 
• Peer review based on a broad spectrum 
of international academic referees
• Assistance of our professional statistician
for every article with statistical analyses
• Fast peer review, by e-mail exchange with
the referees 
• Prompt decisions based on weekly confer-
ences of the Editorial Board
• Prompt notification on the status of your
manuscript by e-mail
• Professional English copy editing
• No page charges and attractive colour 
offprints at no extra cost
Editorial Board
Prof. Jean-Michel Dayer, Geneva
Prof. Peter Gehr, Berne
Prof. André P. Perruchoud, Basel
Prof. Andreas Schaffner, Zurich 
(Editor in chief)
Prof. Werner Straub, Berne
Prof. Ludwig von Segesser, Lausanne
International Advisory Committee
Prof. K. E. Juhani Airaksinen, Turku, Finland
Prof. Anthony Bayes de Luna, Barcelona, Spain
Prof. Hubert E. Blum, Freiburg, Germany
Prof. Walter E. Haefeli, Heidelberg, Germany
Prof. Nino Kuenzli, Los Angeles, USA
Prof. René Lutter, Amsterdam, 
The Netherlands
Prof. Claude Martin, Marseille, France
Prof. Josef Patsch, Innsbruck, Austria
Prof. Luigi Tavazzi, Pavia, Italy
We evaluate manuscripts of broad clinical
interest from all specialities, including experi-
mental medicine and clinical investigation.
We look forward to receiving your paper!
Guidelines for authors:
http://www.smw.ch/set_authors.html
All manuscripts should be sent in electronic form, to:
EMH Swiss Medical Publishers Ltd.
SMW Editorial Secretariat
Farnsburgerstrasse 8
CH-4132 Muttenz
Manuscripts: submission@smw.ch
Letters to the editor: letters@smw.ch
Editorial Board: red@smw.ch
Internet: http://www.smw.ch
Swiss Medical Weekly: Call for papers
Swiss 
Medical Weekly
The many reasons why you should 
choose SMW to publish your research 
Official journal of
the Swiss Society of Infectious disease
the Swiss Society of Internal Medicine
the Swiss Respiratory Society
Impact factor Swiss Medical Weekly 
0 . 7 7 0
1 . 5 3 7
1 . 1 6 2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
1
9
9
5
1
9
9
6
1
9
9
7
1
9
9
8
1
9
9
9
2
0
0
0
2
0
0
2
2
0
0
3
2
0
0
4
Schweiz Med Wochenschr (1871–2000)
Swiss Med Wkly (continues Schweiz Med Wochenschr from 2001) 
Editores Medicorum Helveticorum
